Combination Therapy With Rapamycin and Low Dose Imatinib in Pulmonary Hypertension
Rationale: Enhanced proliferation and distal migration of human pulmonary arterial smooth muscle cells (hPASMCs) both contribute to the progressive increases in pulmonary vascular remodeling and resistance in pulmonary arterial hypertension (PAH). Our previous studies revealed that Rictor deletion,...
Guardado en:
Autores principales: | Yinan Shi, Chenxin Gu, Tongtong Zhao, Yangfan Jia, Changlei Bao, Ang Luo, Qiang Guo, Ying Han, Jian Wang, Stephen M. Black, Ankit A. Desai, Haiyang Tang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4181b4427f0545c1b2cfbd7f1951f13d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Delivery of Rapamycin by Liposomes Synergistically Enhances the Chemotherapy Effect of 5-Fluorouracil on Colorectal Cancer
por: Chen YQ, et al.
Publicado: (2021) -
Blocking mammalian target of rapamycin (mTOR) improves neuropathic pain evoked by spinal cord injury
por: Wang Xiaoping, et al.
Publicado: (2016) -
NEOADYUVANCIA CON IMATINIB EN EL MANEJO DE GIST GIGANTE DEL TABIQUE RECTOVAGINAL
por: Bannura C,Guillermo, et al.
Publicado: (2014) -
Mycophenolate mofetil versus Rapamycin in Han: SPRD rats with Polycystic Kidney Disease
por: ZHANG,TONG, et al.
Publicado: (2009) -
Leucemia eosinofílica crónica con respuesta hematológica sostenida tras tratamiento con bajas dosis de imatinib
por: Torres C,Demetrio, et al.
Publicado: (2014)